D
Deborah Cromer
Researcher at University of New South Wales
Publications - 84
Citations - 5515
Deborah Cromer is an academic researcher from University of New South Wales. The author has contributed to research in topics: Medicine & Antibody. The author has an hindex of 22, co-authored 61 publications receiving 2009 citations. Previous affiliations of Deborah Cromer include Imperial College London & Kirby Institute.
Papers
More filters
Journal ArticleDOI
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
David S. Khoury,Deborah Cromer,Arnold Reynaldi,Timothy E. Schlub,Timothy E. Schlub,Adam K. Wheatley,Jennifer A Juno,Kanta Subbarao,Stephen J. Kent,Stephen J. Kent,Stephen J. Kent,James A. Triccas,Miles P. Davenport +12 more
TL;DR: It is shown that neutralization level is highly predictive of immune protection, and an evidence-based model of SARS-CoV-2 immune protection that will assist in developing vaccine strategies to control the future trajectory of the pandemic is provided.
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis.
Deborah Cromer,Megan Steain,Arnold Reynaldi,Timothy E. Schlub,Timothy E. Schlub,Adam K. Wheatley,Jennifer A Juno,Stephen J. Kent,Stephen J. Kent,James A. Triccas,David S. Khoury,Miles P. Davenport +11 more
TL;DR: In this paper, the authors explored whether in-vitro neutralization titres remain predictive of vaccine protection from infection with SARS-CoV-2 variants and used the model to predict the impact of booster vaccination on protection against SARS CoV2 variants.
Journal ArticleDOI
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.
Adam K. Wheatley,Jennifer A Juno,Jing J. Wang,Kevin J. Selva,Arnold Reynaldi,Hyon-Xhi Tan,Wen Shi Lee,Kathleen M. Wragg,Hannah G. Kelly,Hannah G. Kelly,Robyn Esterbauer,Robyn Esterbauer,Samantha K Davis,Helen E Kent,Helen E Kent,Francesca L Mordant,Timothy E. Schlub,Timothy E. Schlub,David L. Gordon,David S. Khoury,Kanta Subbarao,Deborah Cromer,Tom P. Gordon,Tom P. Gordon,Amy W. Chung,Miles P. Davenport,Stephen J. Kent,Stephen J. Kent,Stephen J. Kent +28 more
TL;DR: In this paper, the authors show a comprehensive profile of antibody, B cell and T cell dynamics over time in a cohort of patients who have recovered from mild-moderate COVID-19.
Journal ArticleDOI
The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy.
Deborah Cromer,Albert Jan van Hoek,Mark Jit,Mark Jit,W. John Edmunds,Douglas M. Fleming,Elizabeth Miller +6 more
TL;DR: Additional strategies are needed to reduce the remaining morbidity and mortality in the high-risk and elderly populations, and to protect healthy children currently not offered the benefits of vaccination.
Journal ArticleDOI
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Deborah Cromer,Jennifer A Juno,David S. Khoury,Arnold Reynaldi,Adam K. Wheatley,Stephen J. Kent,Miles P. Davenport +6 more
TL;DR: In this article, the authors summarize the current understanding of immune responses to and immune control of SARS-CoV-2 and the implications for prevention of reinfection, which is crucial for rational design and deployment of vaccines and for understanding the possible future trajectories of the pandemic.